7-Oxo-7,8-dihydro-6H-pyrimido[5,4-b][1,4]oxazine-2-carboxaldehyde was used as a reagent in the development and optimization of novel bacterial topoisomerase type II inhibitors which show potential for use in development of antimicrobial agents against drug resistant pseudomonas aeruginosa.